India  

Russia, Dr Reddy’s tie up for Sputnik V trial

IndiaTimes Wednesday, 16 September 2020 ()
Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of Sputnik V vaccine in India with deliveries for general use potentially beginning late this year.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News 01:03

Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's sovereign wealth fund. Upon regulatory approval in India, the RDIF shall supply to Dr Reddy’s 100...

💡 newsR Knowledge: Other News Mentions

Gam-COVID-Vac Gam-COVID-Vac Viral vector vaccine candidate based on human adenovirus

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks

Indian trials of the Sputnik-V vaccine candidate, being developed by Russia`s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at..
DNA

India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks: Dr Reddy's

Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the..
IndiaTimes
Closing bell: Equity indices in positive terrain, Dr Reddy's top gainer [Video]

Closing bell: Equity indices in positive terrain, Dr Reddy's top gainer

Equity benchmark indices traded higher in the afternoon session on September 16 while Asian stocks were flat ahead of the US Federal Reserve's view on the economy. The BSE S-P Sensex closed 259 points or 0.66 per cent at 39,303 while the Nifty 50 gained by 83 points or 0.72 per cent at 11,605. Except for Nifty media and PSU bank, all sectoral indices at the National Stock Exchange were in the positive zone with Nifty realty gaining by 2.2 per cent, pharma by 2 per cent and auto by 1.5 per cent. Among stocks, Dr Reddy's jumped by 4.44 per cent to close at Rs 4,639.60 per share after it announced cooperation with Russian Direct Investment Fund (RDIF) to conduct clinical trials and distribute Sputnik V vaccine in India for treatment of COVID-19. Mahindra - Mahindra accelerated by 4 per cent to Rs 638.05 per share while Bajaj Auto moved up by 3.5 per cent and Tata Motors by 1.7 per cent.

Credit: ANI    Duration: 01:21Published
‘India may help Russia in phase 3 trials & making of Covid vaccine’: VK Paul [Video]

‘India may help Russia in phase 3 trials & making of Covid vaccine’: VK Paul

India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said on Tuesday. "The government of India attaches great importance to this offer of partnership from a friend," said V. K. Paul, member of NITI Aayog.

Credit: HT Digital Content    Duration: 03:32Published

Dr. Reddy's Laboratories Indian multinational pharmaceutical company

Opening Bell: Equity indices in the red amid weak global cues [Video]

Opening Bell: Equity indices in the red amid weak global cues

Equity benchmark indices were down on September 30. At 10:00 am, the BSE was down by 95 points or 0.25 per cent and was trading at 37,876, while Nifty was trading also dipped by 7 points or -0.06 per cent at 11,215. The top gainers in the BSE include Sun Pharma, HUL and Asian Paints. SunPharma was trading up with shares at Rs 512 points up by 1.57 per cent, HUL was at Rs 2,055 and Asian Paints at Rs 1,979. Top gainers at NSE included CIPLA, Dr Reddy and Divi's Laboratories Limited. CIPLA was trading at Rs 789 up by 3.49 per cent, Dr Reddy at Rs 5,225 up by 2.77 per cent and Divi's Laboratories Limited was trading at Rs 3,119.

Credit: ANI    Duration: 01:10Published
Equity indices trade higher, pharma stocks rally [Video]

Equity indices trade higher, pharma stocks rally

Equity benchmark indices traded higher during early hours on Friday amid mixed cues from their Asian peers. At 10:15 am, the BSE S-P Sensex was up by 136 points or 0.35 per cent at 39,115 while the Nifty 50 moved up by 56 points or 0.48 per cent at 11,576. Except for Nifty FMCG, all sectoral indices at the National Stock Exchange were in the green with Nifty pharma gaining by 3.8 per cent, realty by 0.9 per cent and auto by 0.7 per cent. Among stocks, Dr Reddy's Laboratories jumped by 4.6 per cent to Rs 5,051.20 per share after the company said it has settled its patent litigation with Celgene for the latter's cancer drug capsules. Cipla ticked up by 5.4 per cent and Sun Pharma by 3 per cent while Oberoi Realty advanced by 2.4 per cent. Eicher Motors, Adani Ports, Tech Mahindra and Wirpo traded with a positive bias. FMCG stocks fell with Hindustan Uniliver slipping by 1.4 per cent, Nestle India by 0.3 per cent and Britannia by 0.2 per cent.

Credit: ANI    Duration: 01:24Published

Russian Direct Investment Fund Russian Direct Investment Fund Fund established by the Russian government in June 2011


Hyderabad Hyderabad Capital of Telangana, India

Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister [Video]

Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister

Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October. Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3 trial of the vaccine candidate. Bharat Biotech is working with the Indian Council of Medical Research (ICMR) to develop a vaccine candidate – Covaxin. The pharma company recently signed an agreement with the Washington University School of Medicine for an intranasal single-dose vaccine. Watch the full video for more details.

Credit: HT Digital Content    Duration: 02:29Published
IPL 2020: Delhi Capitals to take on Sunrisers Hyderabad in Abu Dhabi [Video]

IPL 2020: Delhi Capitals to take on Sunrisers Hyderabad in Abu Dhabi

Shreyas Iyer-led Delhi Capitals left the hotel in Dubai to lock horns with Sunrisers Hyderabad on September 29. With two straight wins, Delhi Capitals is on the top of the table while Hyderabad is at the bottom. Both the teams will battle for the win in Abu Dhabi.

Credit: ANI    Duration: 01:42Published
World's longest span concrete deck extra-dosed cable stayed bridge inaugurated in Hyderabad [Video]

World's longest span concrete deck extra-dosed cable stayed bridge inaugurated in Hyderabad

Union MoS for Home G Kishan Reddy and Minister of Municipal Administration and Urban Development KT Rama Rao inaugurated the span concrete deck extra-dosed cable-stayed bridge at Durgam Cheruvu of Hyderabad on September 25. Built by Larsen and Toubro, the bridge is expected to ease traffic flow towards HITEC City. It will also reduce commute time from Jubilee Hills to Madhapur from 30 to 10 minutes and the distance from Mind Space to Jubilee Hills by 2 kms. As per media reports, this bridge was constructed at the cost of Rs 184 crore.

Credit: ANI    Duration: 01:45Published

You Might Like


Related videos from verified sources

The scientist behind Russia's 'Sputnik' vaccine [Video]

The scientist behind Russia's 'Sputnik' vaccine

Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the..

Credit: Reuters Studio     Duration: 02:16Published
Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical? [Video]

Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical?

Russia has become the first country to approve a Covid-19 vaccine and it has been named 'Sputnik V'. Russian President Vladimir Putin said that the vaccine was effective and said that one of his..

Credit: HT Digital Content     Duration: 03:03Published

Related news from verified sources

Russia to sell 100 million doses of Covid-19 vaccine to India

Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19...
IndiaTimes

Russia, Dr Reddy’s tie up for Sputnik V trial

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on...
IndiaTimes Also reported by •HinduMid-DayDNA

COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan

Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company...
DNA


Tweets about this

evereeze

evening breeze RT @dna: What is #TelanganaLiberationDay: All you need to know https://t.co/WmHmy3zgE5 6 days ago

robbervadra3

Queen Cobra What is Telangana Liberation Day: All you need to know https://t.co/5sVnDdyHlM 1 week ago

mahmood_saberi

sabs #hyderabad #mergerday #aamirkhan should do a movie on the last days of the fight by the #nizam to remain independen… https://t.co/Zq6n7N5Og4 1 week ago

dna

DNA What is #TelanganaLiberationDay: All you need to know https://t.co/WmHmy3zgE5 1 week ago